

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axon ensheathment in central nervous system (GO:0032291) | 4.71453163 |
| 2 | central nervous system myelination (GO:0022010) | 4.71453163 |
| 3 | neutrophil activation involved in immune response (GO:0002283) | 4.58197251 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.36276138 |
| 5 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.24708574 |
| 6 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.15695400 |
| 7 | fatty acid elongation (GO:0030497) | 4.11303953 |
| 8 | regulation of vitamin metabolic process (GO:0030656) | 3.89896270 |
| 9 | regulation of integrin activation (GO:0033623) | 3.81972311 |
| 10 | amyloid precursor protein metabolic process (GO:0042982) | 3.79910345 |
| 11 | negative regulation of interleukin-12 production (GO:0032695) | 3.79491906 |
| 12 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.69856018 |
| 13 | hemidesmosome assembly (GO:0031581) | 3.63456342 |
| 14 | definitive hemopoiesis (GO:0060216) | 3.56880342 |
| 15 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.55485535 |
| 16 | cell adhesion mediated by integrin (GO:0033627) | 3.53364487 |
| 17 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.48403388 |
| 18 | platelet dense granule organization (GO:0060155) | 3.36738294 |
| 19 | regulation of interferon-alpha production (GO:0032647) | 3.36272555 |
| 20 | regulation of T cell migration (GO:2000404) | 3.29893519 |
| 21 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.24752911 |
| 22 | membrane raft organization (GO:0031579) | 3.24588340 |
| 23 | phagocytosis, engulfment (GO:0006911) | 3.20065005 |
| 24 | positive regulation of type 2 immune response (GO:0002830) | 3.15298277 |
| 25 | cyclooxygenase pathway (GO:0019371) | 3.14458299 |
| 26 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.13452409 |
| 27 | cellular response to interferon-alpha (GO:0035457) | 3.10016707 |
| 28 | mesodermal cell differentiation (GO:0048333) | 3.07689061 |
| 29 | response to interferon-beta (GO:0035456) | 3.04494943 |
| 30 | regulation of lymphocyte migration (GO:2000401) | 3.03630942 |
| 31 | interleukin-6-mediated signaling pathway (GO:0070102) | 3.03610461 |
| 32 | low-density lipoprotein particle clearance (GO:0034383) | 3.00658473 |
| 33 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.00400493 |
| 34 | detection of molecule of bacterial origin (GO:0032490) | 2.99554003 |
| 35 | keratan sulfate catabolic process (GO:0042340) | 2.98775545 |
| 36 | immunoglobulin mediated immune response (GO:0016064) | 2.98621476 |
| 37 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.96815363 |
| 38 | positive regulation of chemokine secretion (GO:0090197) | 2.96491876 |
| 39 | cellular response to ATP (GO:0071318) | 2.95452282 |
| 40 | glycosphingolipid catabolic process (GO:0046479) | 2.94810579 |
| 41 | response to interferon-alpha (GO:0035455) | 2.92706169 |
| 42 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.90474878 |
| 43 | response to lipoprotein particle (GO:0055094) | 2.88799778 |
| 44 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.87858319 |
| 45 | myelin maintenance (GO:0043217) | 2.87739251 |
| 46 | myeloid cell homeostasis (GO:0002262) | 2.85298996 |
| 47 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.84239735 |
| 48 | regulation of fever generation (GO:0031620) | 2.84002423 |
| 49 | ensheathment of neurons (GO:0007272) | 2.83922631 |
| 50 | axon ensheathment (GO:0008366) | 2.83922631 |
| 51 | myelination (GO:0042552) | 2.83609948 |
| 52 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.83453125 |
| 53 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.82268952 |
| 54 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.82028063 |
| 55 | positive regulation of macrophage cytokine production (GO:0060907) | 2.81372152 |
| 56 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.80723779 |
| 57 | regulation of mononuclear cell migration (GO:0071675) | 2.80522519 |
| 58 | amyloid precursor protein catabolic process (GO:0042987) | 2.79494316 |
| 59 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.75846147 |
| 60 | lipoxygenase pathway (GO:0019372) | 2.75248365 |
| 61 | adhesion of symbiont to host cell (GO:0044650) | 2.73941649 |
| 62 | virion attachment to host cell (GO:0019062) | 2.73941649 |
| 63 | skin morphogenesis (GO:0043589) | 2.73452326 |
| 64 | positive regulation of interleukin-6 production (GO:0032755) | 2.72014202 |
| 65 | negative regulation of vascular permeability (GO:0043116) | 2.71967140 |
| 66 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.69184938 |
| 67 | macrophage activation involved in immune response (GO:0002281) | 2.68139534 |
| 68 | hyaluronan catabolic process (GO:0030214) | 2.67378001 |
| 69 | cellular response to type I interferon (GO:0071357) | 2.67332763 |
| 70 | type I interferon signaling pathway (GO:0060337) | 2.67332763 |
| 71 | regulation of podosome assembly (GO:0071801) | 2.67105511 |
| 72 | signal peptide processing (GO:0006465) | 2.66594970 |
| 73 | oligosaccharide catabolic process (GO:0009313) | 2.66297135 |
| 74 | hepatocyte apoptotic process (GO:0097284) | 2.64257758 |
| 75 | response to type I interferon (GO:0034340) | 2.63713820 |
| 76 | respiratory burst (GO:0045730) | 2.62503783 |
| 77 | regulation of chemokine biosynthetic process (GO:0045073) | 2.62107432 |
| 78 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.61409283 |
| 79 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.60850978 |
| 80 | glycolipid catabolic process (GO:0019377) | 2.60307867 |
| 81 | response to peptidoglycan (GO:0032494) | 2.60166514 |
| 82 | B cell mediated immunity (GO:0019724) | 2.60138388 |
| 83 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.60085685 |
| 84 | regulation of growth of symbiont in host (GO:0044126) | 2.60085685 |
| 85 | negative regulation of growth of symbiont in host (GO:0044130) | 2.60085685 |
| 86 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.60085685 |
| 87 | pinocytosis (GO:0006907) | 2.59723345 |
| 88 | cellular response to lipopolysaccharide (GO:0071222) | 2.59646594 |
| 89 | positive regulation of heat generation (GO:0031652) | 2.59628232 |
| 90 | regulation of T-helper cell differentiation (GO:0045622) | 2.59530435 |
| 91 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.59159740 |
| 92 | neutrophil activation (GO:0042119) | 2.58993247 |
| 93 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.58606613 |
| 94 | iron ion import (GO:0097286) | 2.56150906 |
| 95 | wound healing, spreading of epidermal cells (GO:0035313) | 2.56144207 |
| 96 | regulation of type 2 immune response (GO:0002828) | 2.55790630 |
| 97 | regulation of macrophage cytokine production (GO:0010935) | 2.55668878 |
| 98 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.54942173 |
| 99 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.54597422 |
| 100 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.54484414 |
| 101 | regulation of interleukin-8 secretion (GO:2000482) | 2.54294578 |
| 102 | positive regulation of actin filament depolymerization (GO:0030836) | 2.54258022 |
| 103 | positive regulation of interleukin-10 production (GO:0032733) | 2.54228814 |
| 104 | natural killer cell mediated immunity (GO:0002228) | 2.53670611 |
| 105 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.53670611 |
| 106 | regulation of interleukin-12 production (GO:0032655) | 2.53609904 |
| 107 | myeloid cell activation involved in immune response (GO:0002275) | 2.53557751 |
| 108 | apoptotic cell clearance (GO:0043277) | 2.53423175 |
| 109 | response to thyroid hormone (GO:0097066) | 2.53206741 |
| 110 | histamine secretion (GO:0001821) | 2.53016561 |
| 111 | negative regulation of interleukin-8 production (GO:0032717) | 2.52685711 |
| 112 | megakaryocyte development (GO:0035855) | 2.52570054 |
| 113 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.52437589 |
| 114 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.52279860 |
| 115 | regulation of metalloenzyme activity (GO:0048552) | 2.51204932 |
| 116 | T-helper 1 type immune response (GO:0042088) | 2.50198188 |
| 117 | negative regulation of complement activation (GO:0045916) | 2.49756726 |
| 118 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.49551413 |
| 119 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.49466044 |
| 120 | leukocyte degranulation (GO:0043299) | 2.49407219 |
| 121 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.48673532 |
| 122 | cellular response to molecule of bacterial origin (GO:0071219) | 2.48390922 |
| 123 | wound healing, spreading of cells (GO:0044319) | 2.48380748 |
| 124 | chondrocyte proliferation (GO:0035988) | 2.48233764 |
| 125 | cholesterol biosynthetic process (GO:0006695) | 2.47842452 |
| 126 | positive regulation of acute inflammatory response (GO:0002675) | 2.46645119 |
| 127 | vesicle fusion (GO:0006906) | 2.46457832 |
| 128 | mast cell activation (GO:0045576) | 2.46150734 |
| 129 | regulation of monocyte chemotaxis (GO:0090025) | 2.46025154 |
| 130 | response to protozoan (GO:0001562) | 2.45763650 |
| 131 | negative regulation of interleukin-17 production (GO:0032700) | 2.45308372 |
| 132 | regulation of hypersensitivity (GO:0002883) | 2.45111740 |
| 133 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.45048072 |
| 134 | positive regulation of T cell migration (GO:2000406) | 2.44338749 |
| 135 | membrane protein ectodomain proteolysis (GO:0006509) | 2.44321551 |
| 136 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.43899593 |
| 137 | positive regulation of osteoblast proliferation (GO:0033690) | 2.43350545 |
| 138 | sphingosine metabolic process (GO:0006670) | 2.43056608 |
| 139 | cortical actin cytoskeleton organization (GO:0030866) | 2.43005964 |
| 140 | regulation of nitric oxide biosynthetic process (GO:0045428) | 2.42925556 |
| 141 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.42577862 |
| 142 | pore complex assembly (GO:0046931) | 2.42495695 |
| 143 | positive regulation of natural killer cell activation (GO:0032816) | 2.40689533 |
| 144 | integrin-mediated signaling pathway (GO:0007229) | 2.40545767 |
| 145 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.39966339 |
| 146 | regulation of cholesterol storage (GO:0010885) | 2.38293983 |
| 147 | positive regulation of interleukin-12 production (GO:0032735) | 2.38084948 |
| 148 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.38041830 |
| 149 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.37950864 |
| 150 | defense response to protozoan (GO:0042832) | 2.37860596 |
| 151 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.37538361 |
| 152 | granulocyte activation (GO:0036230) | 2.37015564 |
| 153 | extracellular matrix assembly (GO:0085029) | 2.36730490 |
| 154 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.36592128 |
| 155 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.36592128 |
| 156 | modulation by symbiont of host immune response (GO:0052553) | 2.36592128 |
| 157 | positive regulation by symbiont of host defense response (GO:0052509) | 2.36592128 |
| 158 | modulation by symbiont of host defense response (GO:0052031) | 2.36592128 |
| 159 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.36592128 |
| 160 | response to muramyl dipeptide (GO:0032495) | 2.35141254 |
| 161 | regulation of antigen processing and presentation (GO:0002577) | 2.35109738 |
| 162 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.35041077 |
| 163 | osteoclast differentiation (GO:0030316) | 2.34001606 |
| 164 | positive regulation of lymphocyte migration (GO:2000403) | 2.33865450 |
| 165 | negative regulation of bone mineralization (GO:0030502) | 2.33862296 |
| 166 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.32652870 |
| 167 | decidualization (GO:0046697) | 2.32581418 |
| 168 | regulation of necroptotic process (GO:0060544) | 2.32195629 |
| 169 | positive regulation of interferon-alpha production (GO:0032727) | 2.31016549 |
| 170 | sterol biosynthetic process (GO:0016126) | 2.30476305 |
| 171 | regulation of chemokine secretion (GO:0090196) | 2.29823966 |
| 172 | response to fungus (GO:0009620) | 2.29459232 |
| 173 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.28686926 |
| 174 | positive regulation of macrophage differentiation (GO:0045651) | 2.27702904 |
| 175 | negative regulation of biomineral tissue development (GO:0070168) | 2.24953942 |
| 176 | regulation of lymphocyte chemotaxis (GO:1901623) | 2.24920198 |
| 177 | sequestering of metal ion (GO:0051238) | 2.23893339 |
| 178 | cellular response to vitamin D (GO:0071305) | 2.23600952 |
| 179 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.23385809 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.95194721 |
| 2 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.29932914 |
| 3 | GATA1_22025678_ChIP-Seq_K562_Human | 4.03228205 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.02485962 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.84353168 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.80216241 |
| 7 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.74658917 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.55285215 |
| 9 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.12527661 |
| 10 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.99480343 |
| 11 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.99080852 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.97100112 |
| 13 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.90691704 |
| 14 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.84135738 |
| 15 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.69902175 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.69387039 |
| 17 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.56156900 |
| 18 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.48202586 |
| 19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.41568070 |
| 20 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 2.22676658 |
| 21 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.18950370 |
| 22 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.18092003 |
| 23 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.15058324 |
| 24 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.97391210 |
| 25 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.92030984 |
| 26 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.85756254 |
| 27 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.83974824 |
| 28 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.81870492 |
| 29 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.80322643 |
| 30 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.78008257 |
| 31 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.77648899 |
| 32 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.77648899 |
| 33 | * PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.77419845 |
| 34 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.77248415 |
| 35 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.76743869 |
| 36 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.76008988 |
| 37 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.73783564 |
| 38 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.73025014 |
| 39 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.71670848 |
| 40 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.71032890 |
| 41 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.70775729 |
| 42 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.69895720 |
| 43 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.65301959 |
| 44 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63515431 |
| 45 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.62654324 |
| 46 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.57666916 |
| 47 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.56803637 |
| 48 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.56496979 |
| 49 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.54594115 |
| 50 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.54594115 |
| 51 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.54590634 |
| 52 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.49877976 |
| 53 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.46155683 |
| 54 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.43035951 |
| 55 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.43008570 |
| 56 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40543819 |
| 57 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.34873581 |
| 58 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.33642366 |
| 59 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.33621141 |
| 60 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.32388043 |
| 61 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32283567 |
| 62 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.31660630 |
| 63 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.30830961 |
| 64 | MYB_26560356_Chip-Seq_TH2_Human | 1.30039057 |
| 65 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.30012253 |
| 66 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.28822672 |
| 67 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28788794 |
| 68 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.26921507 |
| 69 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.25879650 |
| 70 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.24916245 |
| 71 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.23400369 |
| 72 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.22820463 |
| 73 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22659562 |
| 74 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21746131 |
| 75 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.21336810 |
| 76 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.16469719 |
| 77 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.15993881 |
| 78 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15845225 |
| 79 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.13877184 |
| 80 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.13081159 |
| 81 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.13036085 |
| 82 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.12598244 |
| 83 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.10850507 |
| 84 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.09819359 |
| 85 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08035003 |
| 86 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.07244281 |
| 87 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.06895702 |
| 88 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.06144374 |
| 89 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06003655 |
| 90 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.05821330 |
| 91 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.05689885 |
| 92 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05491130 |
| 93 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.05449561 |
| 94 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.05106734 |
| 95 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.04218622 |
| 96 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.03995292 |
| 97 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.02692409 |
| 98 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.02444396 |
| 99 | MYB_26560356_Chip-Seq_TH1_Human | 1.02361214 |
| 100 | SPI1_23127762_ChIP-Seq_K562_Human | 1.01442477 |
| 101 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00112920 |
| 102 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.99542571 |
| 103 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.99332538 |
| 104 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99283591 |
| 105 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.99184403 |
| 106 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.98646564 |
| 107 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.98517334 |
| 108 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.98047767 |
| 109 | TP53_16413492_ChIP-PET_HCT116_Human | 0.95504413 |
| 110 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.94862417 |
| 111 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.93797544 |
| 112 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.93212640 |
| 113 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.93022943 |
| 114 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91623148 |
| 115 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.91565722 |
| 116 | GATA3_26560356_Chip-Seq_TH2_Human | 0.90619082 |
| 117 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.90459855 |
| 118 | NFI_21473784_ChIP-Seq_ESCs_Mouse | 0.89878107 |
| 119 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.87982776 |
| 120 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.87520883 |
| 121 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.86964477 |
| 122 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84556285 |
| 123 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.83948620 |
| 124 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.83900650 |
| 125 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.83524037 |
| 126 | GATA1_19941826_ChIP-Seq_K562_Human | 0.83028813 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 4.61245209 |
| 2 | MP0003950_abnormal_plasma_membrane | 2.90042175 |
| 3 | * MP0002148_abnormal_hypersensitivity_rea | 2.51467433 |
| 4 | MP0008004_abnormal_stomach_pH | 2.45727318 |
| 5 | MP0006054_spinal_hemorrhage | 2.39737217 |
| 6 | MP0000920_abnormal_myelination | 2.39622550 |
| 7 | MP0005275_abnormal_skin_tensile | 2.39421354 |
| 8 | MP0002396_abnormal_hematopoietic_system | 2.38877997 |
| 9 | MP0005503_abnormal_tendon_morphology | 2.26818481 |
| 10 | MP0001835_abnormal_antigen_presentation | 2.25229620 |
| 11 | MP0005058_abnormal_lysosome_morphology | 2.19662378 |
| 12 | MP0003436_decreased_susceptibility_to | 2.19165554 |
| 13 | MP0003279_aneurysm | 2.10207738 |
| 14 | MP0003724_increased_susceptibility_to | 2.09989397 |
| 15 | MP0006082_CNS_inflammation | 2.09263540 |
| 16 | MP0000465_gastrointestinal_hemorrhage | 2.04848948 |
| 17 | * MP0002419_abnormal_innate_immunity | 2.02951932 |
| 18 | MP0001958_emphysema | 2.02137948 |
| 19 | MP0000685_abnormal_immune_system | 2.02075842 |
| 20 | MP0001533_abnormal_skeleton_physiology | 2.02019194 |
| 21 | MP0005464_abnormal_platelet_physiology | 2.01527305 |
| 22 | MP0009785_altered_susceptibility_to | 1.87149452 |
| 23 | MP0005023_abnormal_wound_healing | 1.87103316 |
| 24 | * MP0005000_abnormal_immune_tolerance | 1.85331371 |
| 25 | MP0001348_abnormal_lacrimal_gland | 1.75234378 |
| 26 | MP0000569_abnormal_digit_pigmentation | 1.71879728 |
| 27 | MP0005025_abnormal_response_to | 1.67379696 |
| 28 | MP0003656_abnormal_erythrocyte_physiolo | 1.63722471 |
| 29 | MP0003806_abnormal_nucleotide_metabolis | 1.62073421 |
| 30 | MP0009764_decreased_sensitivity_to | 1.58633318 |
| 31 | * MP0003075_altered_response_to | 1.57749582 |
| 32 | MP0010352_gastrointestinal_tract_polyps | 1.57054378 |
| 33 | MP0005390_skeleton_phenotype | 1.57018743 |
| 34 | MP0008260_abnormal_autophagy | 1.56355527 |
| 35 | MP0003566_abnormal_cell_adhesion | 1.55582851 |
| 36 | MP0010234_abnormal_vibrissa_follicle | 1.51687853 |
| 37 | MP0001851_eye_inflammation | 1.50984850 |
| 38 | MP0002933_joint_inflammation | 1.50867769 |
| 39 | MP0000343_altered_response_to | 1.49818443 |
| 40 | * MP0002452_abnormal_antigen_presenting | 1.49610235 |
| 41 | MP0005623_abnormal_meninges_morphology | 1.48572391 |
| 42 | MP0001790_abnormal_immune_system | 1.41748887 |
| 43 | MP0005387_immune_system_phenotype | 1.41748887 |
| 44 | MP0010155_abnormal_intestine_physiology | 1.41598788 |
| 45 | MP0000490_abnormal_crypts_of | 1.41003077 |
| 46 | MP0003705_abnormal_hypodermis_morpholog | 1.40845639 |
| 47 | MP0002295_abnormal_pulmonary_circulatio | 1.40581954 |
| 48 | MP0004808_abnormal_hematopoietic_stem | 1.39322611 |
| 49 | MP0001542_abnormal_bone_strength | 1.39012772 |
| 50 | MP0000383_abnormal_hair_follicle | 1.36555246 |
| 51 | MP0002060_abnormal_skin_morphology | 1.36346644 |
| 52 | MP0005257_abnormal_intraocular_pressure | 1.35477298 |
| 53 | MP0004272_abnormal_basement_membrane | 1.33713334 |
| 54 | MP0005508_abnormal_skeleton_morphology | 1.31754505 |
| 55 | MP0003300_gastrointestinal_ulcer | 1.31365820 |
| 56 | * MP0002723_abnormal_immune_serum | 1.30725632 |
| 57 | MP0010678_abnormal_skin_adnexa | 1.28762459 |
| 58 | MP0002998_abnormal_bone_remodeling | 1.26674012 |
| 59 | * MP0002420_abnormal_adaptive_immunity | 1.26669022 |
| 60 | * MP0001819_abnormal_immune_cell | 1.26381339 |
| 61 | MP0005671_abnormal_response_to | 1.25698949 |
| 62 | MP0003091_abnormal_cell_migration | 1.24214728 |
| 63 | MP0003448_altered_tumor_morphology | 1.22461065 |
| 64 | MP0001243_abnormal_dermal_layer | 1.21502506 |
| 65 | MP0002405_respiratory_system_inflammati | 1.20360529 |
| 66 | MP0001986_abnormal_taste_sensitivity | 1.17874838 |
| 67 | MP0003690_abnormal_glial_cell | 1.17563590 |
| 68 | MP0001800_abnormal_humoral_immune | 1.15235348 |
| 69 | MP0009278_abnormal_bone_marrow | 1.15038436 |
| 70 | MP0009384_cardiac_valve_regurgitation | 1.14746844 |
| 71 | MP0004947_skin_inflammation | 1.14623063 |
| 72 | * MP0005165_increased_susceptibility_to | 1.13737638 |
| 73 | MP0005397_hematopoietic_system_phenotyp | 1.11781514 |
| 74 | MP0001545_abnormal_hematopoietic_system | 1.11781514 |
| 75 | MP0002332_abnormal_exercise_endurance | 1.11449399 |
| 76 | MP0002877_abnormal_melanocyte_morpholog | 1.09594251 |
| 77 | MP0000579_abnormal_nail_morphology | 1.08393878 |
| 78 | MP0000372_irregular_coat_pigmentation | 1.07617606 |
| 79 | MP0005451_abnormal_body_composition | 1.07207389 |
| 80 | MP0003303_peritoneal_inflammation | 1.06687975 |
| 81 | MP0001216_abnormal_epidermal_layer | 1.06478322 |
| 82 | MP0000858_altered_metastatic_potential | 1.03472997 |
| 83 | MP0003186_abnormal_redox_activity | 1.03010685 |
| 84 | MP0003172_abnormal_lysosome_physiology | 1.02484497 |
| 85 | MP0003453_abnormal_keratinocyte_physiol | 1.01278125 |
| 86 | MP0000015_abnormal_ear_pigmentation | 1.01225632 |
| 87 | MP0009840_abnormal_foam_cell | 1.01049917 |
| 88 | MP0005171_absent_coat_pigmentation | 1.00725185 |
| 89 | MP0003795_abnormal_bone_structure | 1.00198822 |
| 90 | * MP0005166_decreased_susceptibility_to | 0.99539762 |
| 91 | MP0005167_abnormal_blood-brain_barrier | 0.98256922 |
| 92 | * MP0005164_abnormal_response_to | 0.98091739 |
| 93 | MP0002254_reproductive_system_inflammat | 0.96628021 |
| 94 | MP0001853_heart_inflammation | 0.96552183 |
| 95 | * MP0001845_abnormal_inflammatory_respons | 0.95614569 |
| 96 | MP0004134_abnormal_chest_morphology | 0.94839018 |
| 97 | MP0002166_altered_tumor_susceptibility | 0.93942207 |
| 98 | MP0000767_abnormal_smooth_muscle | 0.92656472 |
| 99 | MP0005666_abnormal_adipose_tissue | 0.92648076 |
| 100 | MP0002006_tumorigenesis | 0.92285607 |
| 101 | MP0009333_abnormal_splenocyte_physiolog | 0.90886906 |
| 102 | MP0003191_abnormal_cellular_cholesterol | 0.88864558 |
| 103 | MP0001849_ear_inflammation | 0.87304315 |
| 104 | MP0000733_abnormal_muscle_development | 0.86846091 |
| 105 | MP0002282_abnormal_trachea_morphology | 0.86713036 |
| 106 | MP0005174_abnormal_tail_pigmentation | 0.86577900 |
| 107 | * MP0000716_abnormal_immune_system | 0.85537185 |
| 108 | MP0001346_abnormal_lacrimal_gland | 0.80836108 |
| 109 | MP0002896_abnormal_bone_mineralization | 0.80529329 |
| 110 | MP0002398_abnormal_bone_marrow | 0.79749116 |
| 111 | MP0010307_abnormal_tumor_latency | 0.79090484 |
| 112 | * MP0008469_abnormal_protein_level | 0.78933899 |
| 113 | MP0001873_stomach_inflammation | 0.77992283 |
| 114 | MP0000371_diluted_coat_color | 0.77577778 |
| 115 | MP0002133_abnormal_respiratory_system | 0.76271516 |
| 116 | MP0005388_respiratory_system_phenotype | 0.76271516 |
| 117 | MP0009765_abnormal_xenobiotic_induced | 0.75976704 |
| 118 | MP0009250_abnormal_appendicular_skeleto | 0.74910525 |
| 119 | MP0003195_calcinosis | 0.74886475 |
| 120 | MP0002009_preneoplasia | 0.74312402 |
| 121 | MP0004147_increased_porphyrin_level | 0.73937867 |
| 122 | * MP0002429_abnormal_blood_cell | 0.73774857 |
| 123 | MP0009763_increased_sensitivity_to | 0.73730042 |
| 124 | MP0004233_abnormal_muscle_weight | 0.73545633 |
| 125 | MP0002113_abnormal_skeleton_development | 0.72689487 |
| 126 | MP0003828_pulmonary_edema | 0.72434752 |
| 127 | MP0005375_adipose_tissue_phenotype | 0.72180065 |
| 128 | MP0005621_abnormal_cell_physiology | 0.71434788 |
| 129 | MP0000689_abnormal_spleen_morphology | 0.70814917 |
| 130 | MP0001915_intracranial_hemorrhage | 0.70402741 |
| 131 | MP0000627_abnormal_mammary_gland | 0.69758158 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Premature rupture of membranes (HP:0001788) | 5.45973110 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.84884620 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.84884620 |
| 4 | Abnormality of glycolipid metabolism (HP:0010969) | 4.84884620 |
| 5 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.87209895 |
| 6 | Osteolytic defects of the hand bones (HP:0009699) | 3.87209895 |
| 7 | Protrusio acetabuli (HP:0003179) | 3.86718395 |
| 8 | Recurrent abscess formation (HP:0002722) | 3.70097007 |
| 9 | Parakeratosis (HP:0001036) | 3.63949909 |
| 10 | Peritonitis (HP:0002586) | 3.48426507 |
| 11 | Atrophic scars (HP:0001075) | 3.39666850 |
| 12 | Recurrent bacterial skin infections (HP:0005406) | 3.35800840 |
| 13 | Aortic dissection (HP:0002647) | 3.34303895 |
| 14 | Vertebral compression fractures (HP:0002953) | 3.26733643 |
| 15 | Petechiae (HP:0000967) | 3.20079264 |
| 16 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.17942900 |
| 17 | Eczematoid dermatitis (HP:0000976) | 3.04579835 |
| 18 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.00932780 |
| 19 | Soft skin (HP:0000977) | 2.99409563 |
| 20 | Purpura (HP:0000979) | 2.94591897 |
| 21 | Onycholysis (HP:0001806) | 2.93955433 |
| 22 | Abnormality of macrophages (HP:0004311) | 2.88877910 |
| 23 | Syringomyelia (HP:0003396) | 2.86149943 |
| 24 | Spinal cord lesions (HP:0100561) | 2.86149943 |
| 25 | Mucopolysacchariduria (HP:0008155) | 2.84569895 |
| 26 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.84569895 |
| 27 | Fragile skin (HP:0001030) | 2.82829752 |
| 28 | Cervical subluxation (HP:0003308) | 2.78805702 |
| 29 | Increased cerebral lipofuscin (HP:0011813) | 2.75417268 |
| 30 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.69509917 |
| 31 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.69509917 |
| 32 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.69509917 |
| 33 | Vacuolated lymphocytes (HP:0001922) | 2.68186082 |
| 34 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.64229482 |
| 35 | Thrombocytosis (HP:0001894) | 2.60028963 |
| 36 | Wormian bones (HP:0002645) | 2.56081969 |
| 37 | Patchy hypopigmentation of hair (HP:0011365) | 2.55408575 |
| 38 | Systemic lupus erythematosus (HP:0002725) | 2.53208619 |
| 39 | Recurrent skin infections (HP:0001581) | 2.51337209 |
| 40 | Milia (HP:0001056) | 2.51085573 |
| 41 | Abnormal platelet volume (HP:0011876) | 2.50901991 |
| 42 | Glomerulonephritis (HP:0000099) | 2.45489248 |
| 43 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.41203400 |
| 44 | Myositis (HP:0100614) | 2.38873230 |
| 45 | White forelock (HP:0002211) | 2.35091035 |
| 46 | Autoimmune thrombocytopenia (HP:0001973) | 2.34587024 |
| 47 | Alopecia of scalp (HP:0002293) | 2.33276070 |
| 48 | Premature skin wrinkling (HP:0100678) | 2.29615348 |
| 49 | Plantar hyperkeratosis (HP:0007556) | 2.28206669 |
| 50 | Cellulitis (HP:0100658) | 2.27473209 |
| 51 | Spondylolisthesis (HP:0003302) | 2.26804114 |
| 52 | Hepatosplenomegaly (HP:0001433) | 2.23580987 |
| 53 | Increased mean platelet volume (HP:0011877) | 2.23579900 |
| 54 | Chronic otitis media (HP:0000389) | 2.23391121 |
| 55 | Stridor (HP:0010307) | 2.22374274 |
| 56 | Neonatal short-limb short stature (HP:0008921) | 2.22148783 |
| 57 | Myocardial infarction (HP:0001658) | 2.21908641 |
| 58 | Axonal loss (HP:0003447) | 2.21162356 |
| 59 | Disinhibition (HP:0000734) | 2.21049284 |
| 60 | Aortic aneurysm (HP:0004942) | 2.20792756 |
| 61 | Delayed cranial suture closure (HP:0000270) | 2.20314615 |
| 62 | Prolonged bleeding time (HP:0003010) | 2.17820884 |
| 63 | Delayed closure of the anterior fontanelle (HP:0001476) | 2.16653423 |
| 64 | Mitral stenosis (HP:0001718) | 2.13895824 |
| 65 | Thick nail (HP:0001805) | 2.12619489 |
| 66 | Prostate neoplasm (HP:0100787) | 2.12048714 |
| 67 | Periodontitis (HP:0000704) | 2.11522083 |
| 68 | Anhidrosis (HP:0000970) | 2.10752282 |
| 69 | Asymmetry of the thorax (HP:0001555) | 2.08526961 |
| 70 | Beaking of vertebral bodies (HP:0004568) | 2.08176699 |
| 71 | Blue sclerae (HP:0000592) | 2.07750488 |
| 72 | Broad face (HP:0000283) | 2.05721946 |
| 73 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.05419672 |
| 74 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.05419672 |
| 75 | Recurrent viral infections (HP:0004429) | 2.03366047 |
| 76 | Neurofibrillary tangles (HP:0002185) | 2.03325154 |
| 77 | Fatigue (HP:0012378) | 2.03035994 |
| 78 | Shallow orbits (HP:0000586) | 2.02901518 |
| 79 | Interstitial pulmonary disease (HP:0006530) | 2.02896011 |
| 80 | Autoimmune hemolytic anemia (HP:0001890) | 2.02295316 |
| 81 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.02274488 |
| 82 | Infantile muscular hypotonia (HP:0008947) | 2.00785019 |
| 83 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.00018682 |
| 84 | Keratoconjunctivitis sicca (HP:0001097) | 1.99559121 |
| 85 | Follicular hyperkeratosis (HP:0007502) | 1.97638701 |
| 86 | Ectropion (HP:0000656) | 1.97405139 |
| 87 | Autoamputation (HP:0001218) | 1.95747665 |
| 88 | Amyloidosis (HP:0011034) | 1.95616136 |
| 89 | Ulnar bowing (HP:0003031) | 1.95019285 |
| 90 | Basal ganglia calcification (HP:0002135) | 1.94142977 |
| 91 | Retrobulbar optic neuritis (HP:0100654) | 1.94125657 |
| 92 | Optic neuritis (HP:0100653) | 1.94125657 |
| 93 | Abnormality of the periventricular white matter (HP:0002518) | 1.93374734 |
| 94 | Ridged nail (HP:0001807) | 1.93229687 |
| 95 | Gingival bleeding (HP:0000225) | 1.92525051 |
| 96 | Nephritis (HP:0000123) | 1.91092145 |
| 97 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.89824463 |
| 98 | Absent frontal sinuses (HP:0002688) | 1.89070957 |
| 99 | Ankyloglossia (HP:0010296) | 1.88435564 |
| 100 | Asplenia (HP:0001746) | 1.88363891 |
| 101 | Aplasia cutis congenita (HP:0001057) | 1.88354810 |
| 102 | Vascular tortuosity (HP:0004948) | 1.88245574 |
| 103 | Orchitis (HP:0100796) | 1.88119728 |
| 104 | Abnormality of the 2nd finger (HP:0004100) | 1.88065200 |
| 105 | Mediastinal lymphadenopathy (HP:0100721) | 1.87953098 |
| 106 | Persistence of primary teeth (HP:0006335) | 1.87620648 |
| 107 | Abnormality of the frontal sinuses (HP:0002687) | 1.87340608 |
| 108 | Nuclear cataract (HP:0100018) | 1.86955376 |
| 109 | Abnormality of the lumbar spine (HP:0100712) | 1.86830902 |
| 110 | Obstructive lung disease (HP:0006536) | 1.86493196 |
| 111 | Chronic obstructive pulmonary disease (HP:0006510) | 1.86493196 |
| 112 | Osteomyelitis (HP:0002754) | 1.86448161 |
| 113 | Nonimmune hydrops fetalis (HP:0001790) | 1.85100412 |
| 114 | Femoral bowing (HP:0002980) | 1.85094832 |
| 115 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.84698898 |
| 116 | Tetraparesis (HP:0002273) | 1.84670788 |
| 117 | Gingivitis (HP:0000230) | 1.83827391 |
| 118 | Bruising susceptibility (HP:0000978) | 1.82353880 |
| 119 | Epistaxis (HP:0000421) | 1.82083027 |
| 120 | Pterygium (HP:0001059) | 1.81796752 |
| 121 | Spontaneous hematomas (HP:0007420) | 1.81315852 |
| 122 | Abnormality of the peritoneum (HP:0002585) | 1.80127626 |
| 123 | Albinism (HP:0001022) | 1.80094420 |
| 124 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.80029227 |
| 125 | Abnormality of dentin (HP:0010299) | 1.79805905 |
| 126 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.79208593 |
| 127 | Recurrent lower respiratory tract infections (HP:0002783) | 1.79165653 |
| 128 | Neoplasm of head and neck (HP:0012288) | 1.78414040 |
| 129 | Esophageal neoplasm (HP:0100751) | 1.78414040 |
| 130 | Recurrent pneumonia (HP:0006532) | 1.78287423 |
| 131 | Upper motor neuron abnormality (HP:0002127) | 1.77510130 |
| 132 | Keratoconjunctivitis (HP:0001096) | 1.77079998 |
| 133 | Esophageal atresia (HP:0002032) | 1.76810274 |
| 134 | Abnormality of the basal ganglia (HP:0002134) | 1.75837342 |
| 135 | Short nail (HP:0001799) | 1.75222460 |
| 136 | Viral hepatitis (HP:0006562) | 1.75186449 |
| 137 | Ovoid vertebral bodies (HP:0003300) | 1.75139910 |
| 138 | Fragile nails (HP:0001808) | 1.75046540 |
| 139 | Biconcave vertebral bodies (HP:0004586) | 1.74508539 |
| 140 | Abnormal delivery (HP:0001787) | 1.74410506 |
| 141 | Increased density of long bones (HP:0006392) | 1.74259691 |
| 142 | J-shaped sella turcica (HP:0002680) | 1.74040433 |
| 143 | Dysostosis multiplex (HP:0000943) | 1.73572131 |
| 144 | Premature loss of primary teeth (HP:0006323) | 1.73362287 |
| 145 | Elbow flexion contracture (HP:0002987) | 1.72241736 |
| 146 | Ankle contracture (HP:0006466) | 1.72224856 |
| 147 | Dilatation of the ascending aorta (HP:0005111) | 1.72083541 |
| 148 | Increased serum ferritin (HP:0003281) | 1.71654316 |
| 149 | Abnormal blistering of the skin (HP:0008066) | 1.71186490 |
| 150 | Urticaria (HP:0001025) | 1.69945831 |
| 151 | Arterial tortuosity (HP:0005116) | 1.69801108 |
| 152 | Cheilitis (HP:0100825) | 1.69785944 |
| 153 | Cutaneous melanoma (HP:0012056) | 1.69412208 |
| 154 | Loss of speech (HP:0002371) | 1.69229741 |
| 155 | Nail dystrophy (HP:0008404) | 1.69082889 |
| 156 | Abnormality of oral frenula (HP:0000190) | 1.68312178 |
| 157 | Abnormality of iron homeostasis (HP:0011031) | 1.67298709 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHB1 | 3.71874921 |
| 2 | PBK | 3.47238488 |
| 3 | PDK2 | 3.43546828 |
| 4 | STK39 | 3.24428437 |
| 5 | MST1R | 2.85155120 |
| 6 | TRPM7 | 2.82321693 |
| 7 | KIT | 2.77102695 |
| 8 | BMPR2 | 2.55384811 |
| 9 | ERBB3 | 2.27735875 |
| 10 | PIM2 | 2.25109957 |
| 11 | ERN1 | 1.97324833 |
| 12 | IRAK4 | 1.90596420 |
| 13 | PRPF4B | 1.87359439 |
| 14 | TGFBR2 | 1.87265963 |
| 15 | CLK1 | 1.81317383 |
| 16 | TTN | 1.76659687 |
| 17 | SCYL2 | 1.75654425 |
| 18 | BLK | 1.74246490 |
| 19 | TESK2 | 1.73924602 |
| 20 | TEC | 1.70506424 |
| 21 | BTK | 1.66490903 |
| 22 | LIMK1 | 1.60070679 |
| 23 | OXSR1 | 1.57707425 |
| 24 | ARAF | 1.54324707 |
| 25 | NME2 | 1.53295824 |
| 26 | MET | 1.53290774 |
| 27 | MAP3K14 | 1.51988885 |
| 28 | DDR2 | 1.51253882 |
| 29 | MST4 | 1.50268939 |
| 30 | PIK3CG | 1.45194379 |
| 31 | JAK1 | 1.44676905 |
| 32 | CSF1R | 1.44512732 |
| 33 | RIPK1 | 1.42781124 |
| 34 | FER | 1.41588849 |
| 35 | MAP3K13 | 1.41030991 |
| 36 | PDGFRA | 1.40527955 |
| 37 | TBK1 | 1.40231365 |
| 38 | IKBKB | 1.39009944 |
| 39 | TESK1 | 1.33077117 |
| 40 | STK10 | 1.32948795 |
| 41 | TAOK2 | 1.30736092 |
| 42 | PIK3CA | 1.28799619 |
| 43 | PAK2 | 1.26859592 |
| 44 | TGFBR1 | 1.26614550 |
| 45 | LRRK2 | 1.21147778 |
| 46 | * MAPKAPK5 | 1.20391935 |
| 47 | JAK3 | 1.19577006 |
| 48 | IKBKE | 1.16479959 |
| 49 | NEK9 | 1.13064499 |
| 50 | NEK1 | 1.12028641 |
| 51 | BMPR1B | 1.10932560 |
| 52 | BCR | 1.10886103 |
| 53 | MAP2K3 | 1.10272638 |
| 54 | TYK2 | 1.09700192 |
| 55 | RIPK4 | 1.08821658 |
| 56 | MATK | 1.07314596 |
| 57 | CCNB1 | 1.07175652 |
| 58 | FGFR2 | 1.05064339 |
| 59 | FLT3 | 0.95236803 |
| 60 | EIF2AK1 | 0.94438658 |
| 61 | HCK | 0.93239475 |
| 62 | IRAK3 | 0.92865646 |
| 63 | MAPKAPK2 | 0.90909857 |
| 64 | LYN | 0.90909696 |
| 65 | LATS2 | 0.90587932 |
| 66 | CSK | 0.89714293 |
| 67 | MARK3 | 0.89382070 |
| 68 | MOS | 0.89057165 |
| 69 | LCK | 0.86652416 |
| 70 | STK4 | 0.84433501 |
| 71 | ITK | 0.83837081 |
| 72 | MYLK | 0.83456319 |
| 73 | CSNK1G3 | 0.83267000 |
| 74 | RPS6KA4 | 0.82084800 |
| 75 | NEK6 | 0.81075239 |
| 76 | STK3 | 0.77258926 |
| 77 | BRSK2 | 0.76841615 |
| 78 | CSNK1A1L | 0.76673207 |
| 79 | JAK2 | 0.76602419 |
| 80 | PAK4 | 0.76058042 |
| 81 | * RPS6KA5 | 0.73520548 |
| 82 | EPHA3 | 0.72854812 |
| 83 | NUAK1 | 0.72309414 |
| 84 | DMPK | 0.70036402 |
| 85 | ABL1 | 0.69448973 |
| 86 | FGR | 0.67462460 |
| 87 | TNK2 | 0.66014412 |
| 88 | RPS6KB2 | 0.65894705 |
| 89 | BMX | 0.65334627 |
| 90 | MAPKAPK3 | 0.63697507 |
| 91 | ZAP70 | 0.63509385 |
| 92 | MAP4K1 | 0.63045848 |
| 93 | STK16 | 0.62315507 |
| 94 | PTK2 | 0.60990249 |
| 95 | FRK | 0.59284827 |
| 96 | ACVR1B | 0.58726761 |
| 97 | VRK1 | 0.58665363 |
| 98 | PKN1 | 0.58469211 |
| 99 | GRK7 | 0.58246522 |
| 100 | PRKG2 | 0.57887229 |
| 101 | PDGFRB | 0.57365640 |
| 102 | SYK | 0.57194008 |
| 103 | PAK1 | 0.56591190 |
| 104 | ZAK | 0.56199525 |
| 105 | TXK | 0.55948082 |
| 106 | EIF2AK2 | 0.55751412 |
| 107 | CSNK1G1 | 0.55146376 |
| 108 | STK24 | 0.53305539 |
| 109 | BRAF | 0.53201962 |
| 110 | CDC7 | 0.52889398 |
| 111 | MAP3K3 | 0.51760429 |
| 112 | WNK4 | 0.51626572 |
| 113 | PTK6 | 0.51530679 |
| 114 | ROCK2 | 0.50776351 |
| 115 | CHUK | 0.49672323 |
| 116 | MAP3K8 | 0.49318609 |
| 117 | TIE1 | 0.48343357 |
| 118 | MAP3K5 | 0.47982627 |
| 119 | MAP3K6 | 0.47670874 |
| 120 | PIM1 | 0.47630259 |
| 121 | RAF1 | 0.47285911 |
| 122 | GSK3A | 0.47096126 |
| 123 | YES1 | 0.46322345 |
| 124 | ABL2 | 0.45693834 |
| 125 | CDC42BPA | 0.45516193 |
| 126 | PRKCQ | 0.45295535 |
| 127 | ADRBK2 | 0.44787802 |
| 128 | CDK6 | 0.44612981 |
| 129 | DAPK3 | 0.43713932 |
| 130 | WNK1 | 0.43260215 |
| 131 | BUB1 | 0.43013568 |
| 132 | FES | 0.41775940 |
| 133 | EGFR | 0.41702339 |
| 134 | MAP2K2 | 0.41643333 |
| 135 | EIF2AK3 | 0.40703399 |
| 136 | IRAK1 | 0.39672686 |
| 137 | MAP3K1 | 0.39665284 |
| 138 | FGFR3 | 0.37633056 |
| 139 | PRKAA2 | 0.37534760 |
| 140 | PDPK1 | 0.37521830 |
| 141 | IRAK2 | 0.37499323 |
| 142 | CAMKK2 | 0.34456346 |
| 143 | EEF2K | 0.30457234 |
| 144 | MAP3K12 | 0.30323118 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.99314276 |
| 2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.80222301 |
| 3 | Malaria_Homo sapiens_hsa05144 | 2.38084679 |
| 4 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 2.32583476 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.21094769 |
| 6 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.18218170 |
| 7 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.93735914 |
| 8 | Protein export_Homo sapiens_hsa03060 | 1.88364757 |
| 9 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.79736605 |
| 10 | Shigellosis_Homo sapiens_hsa05131 | 1.79027521 |
| 11 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.76496279 |
| 12 | Pertussis_Homo sapiens_hsa05133 | 1.74508756 |
| 13 | DNA replication_Homo sapiens_hsa03030 | 1.73697652 |
| 14 | Phagosome_Homo sapiens_hsa04145 | 1.53121614 |
| 15 | Salmonella infection_Homo sapiens_hsa05132 | 1.48931754 |
| 16 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.47040950 |
| 17 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.42252100 |
| 18 | Lysosome_Homo sapiens_hsa04142 | 1.42247481 |
| 19 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.41257803 |
| 20 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.39892136 |
| 21 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.39277882 |
| 22 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.37699527 |
| 23 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.37185923 |
| 24 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.36247929 |
| 25 | Ribosome_Homo sapiens_hsa03010 | 1.36205713 |
| 26 | * Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.35885828 |
| 27 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.33574598 |
| 28 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.32877004 |
| 29 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.32565020 |
| 30 | * Ether lipid metabolism_Homo sapiens_hsa00565 | 1.32010906 |
| 31 | Other glycan degradation_Homo sapiens_hsa00511 | 1.31642613 |
| 32 | * Platelet activation_Homo sapiens_hsa04611 | 1.30640121 |
| 33 | Galactose metabolism_Homo sapiens_hsa00052 | 1.26201902 |
| 34 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.25868652 |
| 35 | Legionellosis_Homo sapiens_hsa05134 | 1.25433740 |
| 36 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.22199263 |
| 37 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.18992779 |
| 38 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.18187830 |
| 39 | Focal adhesion_Homo sapiens_hsa04510 | 1.16597575 |
| 40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.16544727 |
| 41 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.15784375 |
| 42 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.14023132 |
| 43 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.13556146 |
| 44 | Bladder cancer_Homo sapiens_hsa05219 | 1.13201476 |
| 45 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.09497679 |
| 46 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.08520333 |
| 47 | Measles_Homo sapiens_hsa05162 | 1.05559599 |
| 48 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.04847116 |
| 49 | Apoptosis_Homo sapiens_hsa04210 | 1.04400882 |
| 50 | Tuberculosis_Homo sapiens_hsa05152 | 1.03286673 |
| 51 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.02553664 |
| 52 | * Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.99422690 |
| 53 | Allograft rejection_Homo sapiens_hsa05330 | 0.98742811 |
| 54 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.98636575 |
| 55 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.97140008 |
| 56 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.96878044 |
| 57 | Asthma_Homo sapiens_hsa05310 | 0.96377258 |
| 58 | Amoebiasis_Homo sapiens_hsa05146 | 0.95429246 |
| 59 | Proteasome_Homo sapiens_hsa03050 | 0.95042992 |
| 60 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.94236871 |
| 61 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.93142026 |
| 62 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.93089093 |
| 63 | Base excision repair_Homo sapiens_hsa03410 | 0.90009995 |
| 64 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.89322171 |
| 65 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.89302002 |
| 66 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.88915169 |
| 67 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.88216430 |
| 68 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.88168742 |
| 69 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.88069259 |
| 70 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.86327362 |
| 71 | Hepatitis B_Homo sapiens_hsa05161 | 0.85559469 |
| 72 | Mismatch repair_Homo sapiens_hsa03430 | 0.84510951 |
| 73 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.83340999 |
| 74 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.82656623 |
| 75 | Histidine metabolism_Homo sapiens_hsa00340 | 0.82549484 |
| 76 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.82079389 |
| 77 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.81838862 |
| 78 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.80177626 |
| 79 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.77815332 |
| 80 | Homologous recombination_Homo sapiens_hsa03440 | 0.76449281 |
| 81 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.76110930 |
| 82 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.75155020 |
| 83 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.74253746 |
| 84 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.73589120 |
| 85 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.72876078 |
| 86 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.72713203 |
| 87 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.72557947 |
| 88 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.71688378 |
| 89 | Influenza A_Homo sapiens_hsa05164 | 0.71442021 |
| 90 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.69549701 |
| 91 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.69115455 |
| 92 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.68720607 |
| 93 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.68548654 |
| 94 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.66362541 |
| 95 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.65354867 |
| 96 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.63530576 |
| 97 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.61530975 |
| 98 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.59590893 |
| 99 | Viral myocarditis_Homo sapiens_hsa05416 | 0.58933341 |
| 100 | Cell cycle_Homo sapiens_hsa04110 | 0.58786447 |
| 101 | Prion diseases_Homo sapiens_hsa05020 | 0.58706501 |
| 102 | Hepatitis C_Homo sapiens_hsa05160 | 0.58256599 |
| 103 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.55008728 |
| 104 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.51944869 |
| 105 | Pathways in cancer_Homo sapiens_hsa05200 | 0.49759414 |
| 106 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.49695835 |
| 107 | Endocytosis_Homo sapiens_hsa04144 | 0.49275733 |
| 108 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.47266521 |
| 109 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.47022871 |
| 110 | Melanoma_Homo sapiens_hsa05218 | 0.46963527 |
| 111 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.46597747 |
| 112 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.46328294 |
| 113 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.44167039 |
| 114 | Prostate cancer_Homo sapiens_hsa05215 | 0.43265720 |
| 115 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.42692371 |
| 116 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.42108840 |
| 117 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.40355680 |
| 118 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.40107421 |
| 119 | HTLV-I infection_Homo sapiens_hsa05166 | 0.38346680 |
| 120 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.35869423 |
| 121 | Carbon metabolism_Homo sapiens_hsa01200 | 0.31572929 |
| 122 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.30341936 |
| 123 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.28089296 |
| 124 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.26510655 |
| 125 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.26257945 |

